Abstract:Angioimmunoblastic T cell lymphoma (AITL) is a distinct subtype of peripheral T cell lymphoma (PTCL) with 5-year overall survival rates of less than 30%. Although frequent somatic mutations of the epigenetic related genes have been identified in AITL, the molecular pathogenesis mechanisms are still unknown to this disease. T-cell receptor (TCR) signaling is pivotal in T-cell development and function. The T-cell receptor presents on the surface of T lymphocytes, which plays a pivotal in T-cell development and function. Engagement of the TCR by antigen presented on major histocompatibility complex (MHC) molecules regulated cellular proliferation, differentiation and cytokine production. In our study, twelve paired AITL samples were subjected to whole exome sequencing. The somatic TCR signaling related mutations were frequently observed in these patients, such as RHOA (50%), PLCg1 (41.7%), ZAP70 (41.7%), CD28 (25%) and Itk (16.7%). Furthermore, phosphorylated ZAP70, Itk and PLCg1 immunohistochemistry staining analysis were performed in 33 AITL paraffin sections. More than half of the patients exhibited constitutively activated intracellular TCR signaling pathway, which might gain significant attention for its possible pathogenesis role in AITL patients. To further illustrated this hypothesis, the knockdown effect of TCR signaling key regulatory kinase ZAP70 and Itk on cellular functions was by shRNA transfection in T cell lymphoma cell lines. The suppression of these target gene expressions significantly compromises proliferation, adhesion, invasion, and migration of malignant T cells. Meanwhile, the pro-apoptotic effect and G2/M phase cell cycle arrest were also induced by ITK and ZAP70 shRNA transfection. Western Blotting analysis demonstrated that the activation of intracellular TCR and related downstream signal pathways was also strongly reduced post shRNA genetic inhibition. More importantly, the similar results were also confirmed using specific Itk inhibitor BMS-509744 and PLS-6-63. Additionally, the anti-tumor and pro-apoptotic activities of Itk inhibitor also were demonstrated using xenograft mice models. Taken together, the constitutively active TCR signaling pathway suggested a novel candidate therapeutic target for the treatment of AITL.

A New Strategy for Adult T-Cell Leukemia Treatment Targeting Glycogen Synthase Kinase-3β

Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia

Targeting Autophagic Regulation Of Nf Kappa B In Htlv-I Transformed Cells By Geldanamycin - Implications For Therapeutic Interventions

Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia–Lymphoma

AICAR Induces AMPK-Independent Cell Death in Adult T-Cell Leukemia/Lymphoma and Has Anti-Tumor Activity

Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma

Novel Treatments of Adult T Cell Leukemia Lymphoma

KU70 Inhibition Impairs Both Non-Homologous End Joining and Homologous Recombination DNA Damage Repair Through SHP-1 Induced Dephosphorylation of SIRT1 in Adult T-Cell Leukemia-Lymphoma Cells

SRT1720 induces SIRT1‐independent cell death in adult T‐cell leukemia/lymphoma

Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells

Inhibitory effect of a neddylation blockade on HTLV-1-infected T cells via modulation of NF-κB, AP-1, and Akt signaling

Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma

KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target

ID: 239

Dysregulation of Micrornas Involved in HTLV-Associated Adult T-Cell Lymphoma

Glycogen Synthase Kinase 3 Promotes Tyrosine Kinase Inhibitor-Induced Apoptosis in Philadelphia Chromosome-Positive Leukemia Cells by Regulating the Wnt/-Catenin Pathway

The Intracellular Tcr Signaling Pathway As A Novel Therapeutic Target In Aitl Patients

Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma

Primary cells from patients with adult T cell leukemia/lymphoma depend on HTLV-1 Tax expression for NF-κB activation and survival